Literature DB >> 34596755

Expression of glucagon-like peptide 1 receptor in neuropeptide Y neurons of the arcuate nucleus in mice.

Yvette Ruska1, Anett Szilvásy-Szabó1, Dóra Kővári1,2, Andrea Kádár1, Lilla Mácsai3, Richárd Sinkó2,3, Erik Hrabovszky4, Balázs Gereben3, Csaba Fekete5,6.   

Abstract

Glucagon-like peptide 1 (GLP-1) and its agonists exert anorexigenic effect at least partly via acting on GLP-1 receptors (GLP-1R) in the arcuate nucleus (ARC). While the anorexigenic, proopiomelanocortin (POMC) neurons of the ARC were shown previously to express GLP-1R, the putative GLP-1R-content of the orexigenic, neuropeptide Y (NPY) neurons remained so far undetected. As GLP-1R is abundant in the ventromedial ARC, where NPY neurons are located; here, we address the possibility that GLP-1 can act directly on the orexigenic NPY system via GLP-1R. Double-labeling immunocytochemistry and in situ hybridization were performed on tissues of adult male mice to detect GLP-1R in NPY neurons. In double-immunolabeled preparations, GLP-1R-immunoreactivity was observed in NPY neurons and in axons ensheathing the majority of NPY neurons. Ultrastructural studies confirmed that GLP-1R-immunoreactivity is associated with the outer membrane of NPY perikarya as well as with axons forming symmetric type, inhibitory synapses on NPY-containing neurons. Double-labeling in situ hybridization experiments demonstrated the expression of GLP-1R mRNA in approximately 20% of NPY mRNA-containing neurons of the ARC. In summary, our data demonstrate the presence of GLP-1R protein and mRNA in NPY neurons of ARC and also reveal the innervation of NPY neurons by GLP-1R-containing inhibitory neurons. These observations suggest that GLP-1 signaling can influence NPY neurons both directly and indirectly. Furthermore, GLP-1 signaling on energy homeostasis appears to involve both direct and indirect effects of GLP-1 on the orexigenic NPY neurons, in addition to the previously known effects via the anorexigenic POMC neuronal system.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Arcuate nucleus; Energy homeostasis; Glucagon-like peptide 1 receptor; Neuropeptide Y

Mesh:

Substances:

Year:  2021        PMID: 34596755     DOI: 10.1007/s00429-021-02380-y

Source DB:  PubMed          Journal:  Brain Struct Funct        ISSN: 1863-2653            Impact factor:   3.270


  34 in total

1.  The effect of physiological levels of glucagon-like peptide-1 on appetite, gastric emptying, energy and substrate metabolism in obesity.

Authors:  A Flint; A Raben; A K Ersbøll; J J Holst; A Astrup
Journal:  Int J Obes Relat Metab Disord       Date:  2001-06

Review 2.  The value of short- and long-acting glucagon-like peptide-1 agonists in the management of type 2 diabetes mellitus: experience with exenatide.

Authors:  Xiao-Hui Guo
Journal:  Curr Med Res Opin       Date:  2015-11-11       Impact factor: 2.580

3.  Expression of the glucagon-like peptide-1 receptor gene in rat brain.

Authors:  E Alvarez; I Roncero; J A Chowen; B Thorens; E Blázquez
Journal:  J Neurochem       Date:  1996-03       Impact factor: 5.372

Review 4.  Gut-brain connection: The neuroprotective effects of the anti-diabetic drug liraglutide.

Authors:  Emanuel Monteiro Candeias; Inês Carolina Sebastião; Susana Maria Cardoso; Sónia Catarina Correia; Cristina Isabel Carvalho; Ana Isabel Plácido; Maria Sancha Santos; Catarina Resende Oliveira; Paula Isabel Moreira; Ana Isabel Duarte
Journal:  World J Diabetes       Date:  2015-06-25

Review 5.  Biologic actions and therapeutic potential of the proglucagon-derived peptides.

Authors:  Daniel J Drucker
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2005-11

6.  Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study.

Authors:  Arne Astrup; Stephan Rössner; Luc Van Gaal; Aila Rissanen; Leo Niskanen; Mazin Al Hakim; Jesper Madsen; Mads F Rasmussen; Michael E J Lean
Journal:  Lancet       Date:  2009-10-23       Impact factor: 79.321

7.  Semaglutide lowers body weight in rodents via distributed neural pathways.

Authors:  Sanaz Gabery; Casper G Salinas; Sarah J Paulsen; Jonas Ahnfelt-Rønne; Tomas Alanentalo; Arian F Baquero; Stephen T Buckley; Erzsébet Farkas; Csaba Fekete; Klaus S Frederiksen; Hans Christian C Helms; Jacob F Jeppesen; Linu M John; Charles Pyke; Jane Nøhr; Tess T Lu; Joseph Polex-Wolf; Vincent Prevot; Kirsten Raun; Lotte Simonsen; Gao Sun; Anett Szilvásy-Szabó; Hanni Willenbrock; Anna Secher; Lotte Bjerre Knudsen; Wouter Frederik Johan Hogendorf
Journal:  JCI Insight       Date:  2020-03-26

8.  Distribution and ultrastructural localization of the glucagon-like peptide-1 receptor (GLP-1R) in the rat brain.

Authors:  Erzsébet Farkas; Anett Szilvásy-Szabó; Yvette Ruska; Richárd Sinkó; Morten Grønbech Rasch; Thomas Egebjerg; Charles Pyke; Balázs Gereben; Lotte Bjerre Knudsen; Csaba Fekete
Journal:  Brain Struct Funct       Date:  2020-12-20       Impact factor: 3.270

9.  A novel mouse model of glucagon-like peptide-1 receptor expression: A look at the brain.

Authors:  Devon L Graham; Heather H Durai; Taylor S Trammell; Brenda L Noble; Douglas P Mortlock; Aurelio Galli; Gregg D Stanwood
Journal:  J Comp Neurol       Date:  2020-03-29       Impact factor: 3.215

10.  Distribution and characterisation of Glucagon-like peptide-1 receptor expressing cells in the mouse brain.

Authors:  Simon C Cork; James E Richards; Marie K Holt; Fiona M Gribble; Frank Reimann; Stefan Trapp
Journal:  Mol Metab       Date:  2015-08-05       Impact factor: 7.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.